| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.76B | 6.58B | 6.49B | 5.94B | 4.97B | 4.29B |
| Gross Profit | 935.00M | 1.05B | 1.04B | 1.01B | 820.10M | 806.85M |
| EBITDA | 98.00M | 198.00M | 295.00M | 300.29M | 214.32M | 228.47M |
| Net Income | 17.00M | 91.00M | 171.00M | 179.35M | 124.08M | 138.24M |
Balance Sheet | ||||||
| Total Assets | 2.01B | 2.60B | 2.12B | 2.04B | 1.75B | 1.58B |
| Cash, Cash Equivalents and Short-Term Investments | 519.00M | 1.05B | 709.00M | 765.90M | 607.60M | 589.38M |
| Total Debt | 436.00M | 435.00M | 427.00M | 424.99M | 433.59M | 433.69M |
| Total Liabilities | 1.93B | 2.50B | 2.03B | 1.96B | 1.75B | 1.54B |
| Stockholders Equity | 87.00M | 97.00M | 94.00M | 81.28M | -1.77M | 44.13M |
Cash Flow | ||||||
| Free Cash Flow | 51.00M | 482.00M | 158.37M | 317.36M | 227.25M | 248.19M |
| Operating Cash Flow | 86.00M | 520.00M | 198.49M | 347.69M | 260.15M | 346.35M |
| Investing Cash Flow | -35.00M | -38.00M | -21.73M | -32.12M | -31.01M | -98.62M |
| Financing Cash Flow | -111.00M | -173.00M | -155.01M | -141.15M | -208.07M | -53.58M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | $3.40B | 13.81 | 13.55% | 2.81% | 0.79% | 34.85% | |
65 Neutral | $1.03B | 19.80 | 24.08% | 0.92% | 9.64% | 9.93% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | $2.63B | 16.89 | 11.27% | 8.66% | -7.27% | -43.88% | |
60 Neutral | $2.79B | 21.19 | 111.30% | 1.93% | 0.99% | -47.02% | |
47 Neutral | $1.28B | 77.05 | 16.04% | 7.04% | 3.19% | -86.21% | |
46 Neutral | $1.38B | ― | -1.00% | 7.87% | -2.44% | -156.01% |
The recent earnings call for Insperity painted a mixed picture, with notable achievements being overshadowed by financial challenges. The company celebrated strong client retention, the rollout of HRScale, and strategic partnerships. However, these positives were tempered by unexpected health benefits costs and an earnings shortfall, contributing to a generally negative outlook.
Insperity, Inc. is a prominent provider of human resources and business performance solutions, offering comprehensive HR services and technology to enhance business performance across the United States.
On November 3, 2025, Insperity announced an amendment to its arrangement with UnitedHealthcare, extending the contract through 2028 and introducing cost-saving measures starting in 2026. This strategic move is expected to enhance Insperity’s financial outlook and align with its growth and profitability goals. Additionally, Insperity reported its third-quarter results, highlighting a 4% revenue increase despite a net loss of $20 million due to elevated healthcare costs. The company is actively working on sustainable profitability and has launched HRScale, a joint solution with Workday, to strengthen its market position.
The most recent analyst rating on (NSP) stock is a Hold with a $48.00 price target. To see the full list of analyst forecasts on Insperity stock, see the NSP Stock Forecast page.